Found 46 matching trials
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases EARLY_PHASE1 This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Learn More & Join Trial
Universal CAR-T Cells Targeting Multiple Myeloma PHASE1 The aim of this study is to assess the feasibility, safety and efficacy of ...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus PHASE1 To assess the safety tolerability pharmacokinetics and pharmacodynamics of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Autologous CARTmeso/19 Against Pancreatic Cancer EARLY_PHASE1 Pancreatic cancer patients receive chimeric antigen receptor (CAR) T cells ...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) PHASE1 The purpose of this study is to evaluate the safety, tolerability, efficacy...
Show More Status
Active Not Recruiting
Location
Local Institution - 0011
Learn More & Join Trial
Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia PHASE1 This study aims to evaluate the safety and clinical activity of CD19 Chimer...
Show More Location
Multiple Locations
Learn More & Join Trial
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus PHASE1 This is a phase I, open-label, single-arm, multicenter study to asess the s...
Show More Location
Relma-cel Medical
Learn More & Join Trial
A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This is a Phase 1, first-in-human, open-label, multicenter study of CC-9754...
Show More Location
Local Institution - 003
Learn More & Join Trial
CAR-T Cell Therapy for Desensitization in Kidney Transplantation PHASE1 This research study is for people who have been waiting for a kidney transp...
Show More Location
Massachusetts General Hospital: Transplantation (Site #: 71107)
Learn More & Join Trial
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases NA This is an open label, single-site, dose-escalation study in up to 18 parti...
Show More Location
Hunan Siweikang Therapeutic Co.Ltd
Learn More & Join Trial